Renal vein thrombosis (RVT) is a blood clot that forms in one or both of the veins that drain blood from the kidneys. It’s uncommon but clinically significant — if not caught early, it can lead to acute kidney injury, renal infarction, and even life-threatening pulmonary embolism. The most common cause in adults is nephrotic syndrome, which accounts for roughly 25–30% of all RVT cases.
The tricky part? RVT often develops silently, especially in chronic cases. Many patients have no flank pain, no visible blood in the urine — just gradually worsening proteinuria or unexplained decline in kidney function. That’s why clinicians need a high index of suspicion, particularly in patients with known hypercoagulable states or nephrotic-range proteinuria (≥3.5 g/day).
What Causes Renal Vein Thrombosis?
RVT follows the same basic principles as any venous thrombosis — Virchow’s triad of stasis, endothelial injury, and hypercoagulability. But the specific triggers tend to differ between adults, children, and neonates.
Adults
Nephrotic syndrome is the leading risk factor. The massive urinary protein loss depletes antithrombin III, protein C, and protein S — natural anticoagulants your body needs to keep clotting in check. Membranous nephropathy carries the highest RVT risk among nephrotic syndrome subtypes, with some studies estimating RVT prevalence at 37% in these patients.
Other adult risk factors include:
- Malignancy — especially renal cell carcinoma, which can directly invade the renal vein
- Antiphospholipid syndrome and other acquired thrombophilias
- Inherited thrombophilias — Factor V Leiden, prothrombin gene mutation (G20210A)
- Oral contraceptives or hormone replacement therapy — estrogen promotes a prothrombotic state
- Abdominal surgery or trauma — direct injury to the renal vasculature
- Extrinsic compression — from tumors, retroperitoneal fibrosis, or aortic aneurysm
Neonates and Infants
In newborns, severe dehydration is the most common trigger. Birth asphyxia, sepsis, and maternal diabetes are additional risk factors. Neonatal RVT accounts for approximately 10–20% of all neonatal venous thrombotic events.
Symptoms: Acute vs. Chronic Presentation
The clinical picture depends heavily on how quickly the clot forms and whether it’s unilateral or bilateral.
| Feature | Acute RVT | Chronic RVT |
|---|---|---|
| Onset | Hours to days | Weeks to months |
| Flank pain | Sudden, severe | Absent or mild |
| Hematuria | Gross (visible) in many cases | Microscopic or absent |
| Proteinuria | New onset or worsening | Gradually increasing |
| Kidney function | Rapid creatinine rise | Slow, insidious decline |
| Kidney size on imaging | Enlarged, edematous | May be atrophic |
| Risk of PE | ~30% of cases | Lower but still present |
Bilateral RVT is a medical emergency. If both renal veins are occluded simultaneously, patients can develop acute kidney failure requiring urgent intervention.
One easily missed sign: in left-sided RVT, men may develop a left-sided varicocele because the left testicular vein drains into the left renal vein. A new varicocele in an older man should prompt further workup.
How Is Renal Vein Thrombosis Diagnosed?
Doppler ultrasound is the usual first-line imaging study. It’s noninvasive, readily available, and can show absent or reversed flow in the renal vein. Sensitivity ranges from 60–80%, though it can be limited by body habitus and bowel gas.
CT venography with contrast is the gold standard for most clinicians. It provides excellent visualization of the thrombus, can assess the extent of clot into the inferior vena cava (IVC), and rules out other pathology like tumors. Sensitivity exceeds 90%.
MR venography is an alternative when contrast CT is contraindicated (e.g., contrast allergy, severe renal insufficiency where gadolinium risks are weighed carefully).
Lab work should include:
- Serum creatinine and BUN (kidney function)
- Urinalysis — look for hematuria and proteinuria
- Complete blood count — thrombocytopenia may suggest consumptive coagulopathy
- D-dimer — elevated in most cases, though nonspecific
- Thrombophilia panel — if no obvious cause is found
- 24-hour urine protein — to assess for nephrotic syndrome
Treatment Options for Renal Vein Thrombosis
Anticoagulation
Systemic anticoagulation is the mainstay of treatment. Most patients start on heparin (unfractionated or low-molecular-weight) and transition to warfarin or a direct oral anticoagulant (DOAC). Duration of therapy is typically 6–12 months, though patients with ongoing risk factors like persistent nephrotic syndrome may need indefinite anticoagulation.
Thrombolysis and Thrombectomy
In severe cases — bilateral RVT with acute kidney failure or massive IVC extension — catheter-directed thrombolysis or surgical thrombectomy may be considered. These are reserved for patients who are deteriorating despite anticoagulation, because the bleeding risks are substantial.
Treating the Underlying Cause
This is just as important as treating the clot itself. If nephrotic syndrome is the driver, immunosuppressive therapy to reduce proteinuria is essential. If a renal cell carcinoma is invading the vein, oncologic surgery takes priority. Without addressing the root cause, recurrence risk remains high.
Prognosis
With prompt anticoagulation, most adults with unilateral RVT recover kidney function. Chronic cases with established renal atrophy may have irreversible damage. The mortality risk is more closely tied to complications like pulmonary embolism — which occurs in up to 30% of acute RVT cases — than to the kidney injury itself.
When to See a Doctor
Seek urgent medical attention if you experience:
- Sudden, severe flank pain with blood in your urine
- New swelling in your legs or abdomen, especially if you have known kidney disease
- Unexplained shortness of breath or chest pain (may indicate pulmonary embolism)
- A sudden decrease in urine output
If you have nephrotic syndrome, ask your nephrologist specifically about your RVT risk. Patients with membranous nephropathy and serum albumin below 2.5 g/dL are at particularly high risk, and some experts advocate prophylactic anticoagulation in this group — though this remains debated.
Frequently Asked Questions
Can renal vein thrombosis cause permanent kidney damage?
Yes, but it depends on timing. Acute unilateral RVT caught early and treated with anticoagulation usually allows good recovery. Chronic RVT or bilateral involvement can cause irreversible renal atrophy and chronic kidney disease. The key is early diagnosis.
Is renal vein thrombosis the same as a kidney embolism?
No. RVT affects the venous drainage — blood leaving the kidney. A renal artery embolism blocks arterial supply — blood flowing into the kidney. Arterial occlusion tends to cause more severe, immediate renal infarction. Both are emergencies, but the treatment strategies differ.
How common is renal vein thrombosis?
RVT is rare in the general population. However, among patients with nephrotic syndrome, the incidence is estimated at 5–62% depending on the underlying glomerular disease and how aggressively imaging is performed. Membranous nephropathy has the highest reported rates.
Can DOACs (like rivaroxaban or apixaban) be used instead of warfarin?
Increasingly, yes. While warfarin has been the traditional choice, DOACs are being used more frequently for venous thromboembolism in general. However, data specific to RVT with DOACs is limited, and patients with severe nephrotic syndrome and very low albumin may have altered drug pharmacokinetics. Discuss the best option with your hematologist or nephrologist.
Should patients with nephrotic syndrome take blood thinners to prevent RVT?
This is one of nephrology’s ongoing debates. Some guidelines suggest prophylactic anticoagulation when serum albumin drops below 2.0–2.5 g/dL, especially in membranous nephropathy. Others recommend it only after a confirmed thrombotic event. The decision is individualized based on bleeding risk, albumin level, and underlying pathology.
